Skip to content
  • FDA Insights on GMP Violations & AAHP Homeopathic 483 Study Webinar

    GMP and compliance-related issues remain a leading cause of FDA warning letters and enforcement actions across the homeopathic industry. This webinar brings together regulatory perspective and industry expertise to help manufacturers better understand what FDA is seeing—and expecting—during inspections.

    Attendees will gain practical insight into recent enforcement actions, as well as a deeper understanding of common compliance gaps observed during facility inspections.

Scroll To Top